Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04735406 · ClinicalTrials.gov registry record
The MS-LINK™ Outcomes Study
A clinical trial of Multiple Sclerosis, sponsored by EMD Serono Research & Development Institute.
- Completed
- Registry status
- 2,182
- Enrollment target
- 9
- Study locations
NCT04735406: Completed study of Multiple Sclerosis, sponsored by EMD Serono Research & Development Institute.
NCT04735406 is a study of Multiple Sclerosis that has completed, run by EMD Serono Research & Development Institute. The registered enrollment target is 2,182 participants, above the 578-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (278% higher). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04735406, a study of Multiple Sclerosis, has completed, sponsored by EMD Serono Research & Development Institute.
- COMPLETED
- Registry status
- 2,182 participants
- Enrollment target
- 9
- Study locations
Study Summary
The Multiple Sclerosis (MS) Leadership and Innovation Network (MS-LINK™) is comprised of networks working cooperatively to advance Multiple Sclerosis (MS) science and improve MS participant outcomes. In this study participants will be followed from the time of consent through the lifetime of the study (currently 3 years), unless the participant chooses to withdraw from the study. Collection of participant's medical history, including MS and treatment history, will be automated through extraction from the participant's electronic medical record (EMR) and other health information systems (for example, radiology). Participants will complete patient-reported outcomes (PROs) and other health-related information digitally. Participating participants will have access to their own data in an ongoing manner via a web-based Participant Portal.
Conditions Studied
Study Locations (9)
Texas
- The University of Texas of Austin - Austin
- University of Texas Health - San Antonio
Alabama
- Alabama Neurology Associates - Birmingham
District of Columbia
- Georgetown University - Washington D.C.
Georgia
- Atlanta Neuroscience Institute - Atlanta
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Michigan
- Memorial healthcare - Owosso
Nebraska
- University of Nebraska medical Center - Omaha
Oklahoma
- The Oklahoma Medical Research Foundation - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,182 participants |
| Start Date | 2021-03-24 |
| Est. Completion | 2024-05-31 |
What the finished NCT04735406 record still lists
NCT04735406 is an observational study that tracks outcomes without assigning an intervention. Its 2,182 participants enrollment target places it among the larger protocols in the corpus, above the 578-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (278% higher).
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT04735406 lists 9 locations in 8 states (Texas, Alabama, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT04735406 about?
NCT04735406 is a clinical study titled "The MS-LINK™ Outcomes Study". The Multiple Sclerosis (MS) Leadership and Innovation Network (MS-LINK™) is comprised of networks working cooperatively to advance Multiple Sclerosis (MS) science and improve MS participant outcomes. In this study participants will be followed from the time of consent through the lifetime of the stu...
What is the current status of trial NCT04735406?
This trial is currently completed. The enrollment target is 2,182 participants. The study started on 2021-03-24. Estimated completion is 2024-05-31.
What conditions does trial NCT04735406 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
Who is sponsoring clinical trial NCT04735406?
This trial is sponsored by EMD Serono Research & Development Institute, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04735406 being conducted?
This trial has 9 study locations across Alabama, District of Columbia, Georgia, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04735406's enrollment target sits among peer trials
2,182 14th of 315 higher than 302 of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05917652 · 2,183 participants
The Actuate-CBC Study
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI